MILEPOST Multicenter Randomized Controlled Trial: 12-Month Weight Loss and Satiety Outcomes After pose SM vs. Medical Therapy
- PMID: 27468907
- DOI: 10.1007/s11695-016-2295-9
MILEPOST Multicenter Randomized Controlled Trial: 12-Month Weight Loss and Satiety Outcomes After pose SM vs. Medical Therapy
Abstract
Background: Pose SM is an endolumenal weight-loss intervention in which suture anchors are placed endoscopically in the gastric fundus/distal gastric body. Observational studies of pose have shown safe, effective weight loss. Twelve-month results of a randomized controlled trial comparing weight loss and satiety after pose vs. conventional medical therapy are reported.
Methods: Subjects with classes I-II obesity were randomized in a 3:1 ratio to pose or diet/exercise guidance only (control). Pose subjects received gastric fundus and distal body suture-anchor plications with diet/exercise counseling. Total body (%TBWL) and excess weight loss (%EWL) were assessed at 6 and 12 months. Analysis of covariance (ANCOVA) was used to analyze 12-month %TBWL. Satiety changes were assessed at 6 and 12 months.
Results: From November 2013 to July 2014, 44 subjects were randomized (34, 77.3 % female; mean age, 38.3 ± 10.7 years; body mass index, 36.5 ± 3.4 kg/m2) to pose (n = 34) or control (n = 10) groups in three centers. Mean pose procedure time was 51.8 ± 14.5 min; pose subjects received a mean 8.8 ± 1.3 fundal and 4.2 ± 0.7 distal body plications. Twelve-month TBWL: pose, 13.0 % (EWL, 45.0 %), n = 30 vs. control group, 5.3 % (18.1 %), n = 9; significant mean difference, 7.7 % (95 % CI 2.2, 13.2; p < 0.01). Pose subjects showed significant reductions in satiety parameters (p < 0.001); controls experienced reduced caloric intake and satiety volume (p < 0.05). No serious device- or procedure-related adverse events occurred.
Conclusions: In a randomized controlled trial at 12 months, pose-treated subjects had significantly greater weight loss than those treated with diet/exercise guidance alone. At 6 and 12 months, pose subjects showed significant reduction in satiety parameters.
Study registration: clinicaltrials.gov identifier # NCT01843231.
Keywords: Bariatric; Endoscopic; Satiety; Weight loss; pose.
Similar articles
-
Gastrointestinal Physiological Changes and Their Relationship to Weight Loss Following the POSE Procedure.Obes Surg. 2016 May;26(5):1081-9. doi: 10.1007/s11695-015-1863-8. Obes Surg. 2016. PMID: 26337693
-
Early experience with the Incisionless Operating Platform™ (IOP) for the treatment of obesity : the Primary Obesity Surgery Endolumenal (POSE) procedure.Obes Surg. 2013 Sep;23(9):1375-83. doi: 10.1007/s11695-013-0937-8. Obes Surg. 2013. PMID: 23591548
-
Prospective Multicenter Study of the Primary Obesity Surgery Endoluminal (POSE 2.0) Procedure for Treatment of Obesity.Clin Gastroenterol Hepatol. 2023 Jan;21(1):81-89.e4. doi: 10.1016/j.cgh.2022.04.019. Epub 2022 May 6. Clin Gastroenterol Hepatol. 2023. PMID: 35533995
-
Intragastric Balloon Treatment for Obesity: Review of Recent Studies.Adv Ther. 2017 Aug;34(8):1859-1875. doi: 10.1007/s12325-017-0562-3. Epub 2017 Jul 13. Adv Ther. 2017. PMID: 28707286 Review.
-
Primary obesity surgery endoluminal (POSE) for the treatment of obesity: a systematic review and meta-analysis.Surg Endosc. 2022 Jan;36(1):252-266. doi: 10.1007/s00464-020-08267-z. Epub 2021 Feb 1. Surg Endosc. 2022. PMID: 33523277 Free PMC article.
Cited by
-
Reinforced POSE: the 18-Plication Solution.Obes Surg. 2019 Nov;29(11):3443-3447. doi: 10.1007/s11695-019-04014-z. Obes Surg. 2019. PMID: 31222496 Clinical Trial.
-
Endoscopic Gastric Plication for Morbid Obesity: a Systematic Review and Meta-analysis of Published Data over Time.Obes Surg. 2019 Sep;29(9):3021-3029. doi: 10.1007/s11695-019-04010-3. Obes Surg. 2019. PMID: 31230201
-
Training in Bariatric and Metabolic Endoscopic Therapies.Clin Endosc. 2018 Sep;51(5):430-438. doi: 10.5946/ce.2018.148. Epub 2018 Sep 30. Clin Endosc. 2018. PMID: 30301319 Free PMC article.
-
Adherence to Healthy Lifestyle Habits Is a Determinant of the Effectiveness of Weight Loss among Patients Undergoing Endoscopic Bariatric Therapies.Nutrients. 2022 May 28;14(11):2261. doi: 10.3390/nu14112261. Nutrients. 2022. PMID: 35684061 Free PMC article.
-
Efficacy of Endoscopic Interventions for the Management of Obesity: a Meta-analysis to Compare Endoscopic Sleeve Gastroplasty, AspireAssist, and Primary Obesity Surgery Endolumenal.Obes Surg. 2019 Jul;29(7):2287-2298. doi: 10.1007/s11695-019-03865-w. Obes Surg. 2019. PMID: 30982170
References
Publication types
MeSH terms
Associated data
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical